HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sustained response to etanercept after failing infliximab, in a patient with relapsing polychondritis with tracheomalacia.

AuthorsP Subrahmanyam, C Balakrishnan, B Dasgupta
JournalScandinavian journal of rheumatology (Scand J Rheumatol) 2008 May-Jun Vol. 37 Issue 3 Pg. 239-40 ISSN: 0300-9742 [Print] England
PMID18465465 (Publication Type: Case Reports, Letter)
Chemical References
  • Anti-Inflammatory Agents
  • Antibodies, Monoclonal
  • Immunoglobulin G
  • Immunologic Factors
  • Receptors, Tumor Necrosis Factor
  • Infliximab
  • Etanercept
Topics
  • Anti-Inflammatory Agents (therapeutic use)
  • Antibodies, Monoclonal (therapeutic use)
  • Etanercept
  • Female
  • Humans
  • Immunoglobulin G (therapeutic use)
  • Immunologic Factors (therapeutic use)
  • Infliximab
  • Middle Aged
  • Polychondritis, Relapsing (complications, drug therapy)
  • Receptors, Tumor Necrosis Factor (therapeutic use)
  • Tracheal Diseases (etiology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: